You have 9 free searches left this month | for more free features.

Condition

Chronic Obstructive Pulmonary Disease (4)

COPD (1)

Overall Status

Not yet recruiting (3)

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 3 (3)

phase 1 (1)

phase 2 (1)

Sponsor

Verona Pharma plc (3)

Nuance Pharma (shanghai) Co., Ltd (2)

Collaborator

Iqvia Pty Ltd (2)

Laboratory Corporation of America (1)

University of Alabama at Birmingham (1)

Intervention

ensifentrine (5)

placebo (4)

Study Documents

Intervention Type

drug (5)

Funder Type

Industry (5)

Study Type

Interventional (5)

ensifentrine

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

COPD Trial in Changsha (Ensifentrine)

Not yet recruiting

Chronic Obstructive Pulmonary Disease

Ensifentrine

Changsha, Hunan, China

The Third Hospital of Changsha

Feb 24, 2023

COPD Trial in Guangzhou (Ensifentrine, Placebo)

Not yet recruiting

Chronic Obstructive Pulmonary Disease

Ensifentrine
Placebo

Guangzhou, Guangdong, China

1st Affiliated Hospital of Guangzhou Medical University

Feb 28, 2023

COPD Trial (Ensifentrine, Placebo)

Not yet recruiting

COPD

Ensifentrine
Placebo

(no location specified)

Feb 22, 2022

COPD Trial in Worldwide (Ensifentrine, Placebo)

Active, not recruiting

Chronic Obstructive Pulmonary Disease

Ensifentrine
Placebo

Peoria, Arizona
+133 more

Dec 5, 2022

COPD Trial in Worldwide (Ensifentrine, Placebo)

Completed

Chronic Obstructive Pulmonary Disease

Ensifentrine
Placebo

Alabaster, Alabama
+140 more

Nov 30, 2022